Franklin Biotechnology Discovery Fund Advisor Class
FTDZX
NASDAQ
| Weiss Ratings | FTDZX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Reward Grade | C | |||
| Risk Index | Fair | |||
| Risk Grade | C | |||
| Company Info | FTDZX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Provider | Franklin Templeton Investments | |||
| Manager/Tenure (Years) | Evan S. McCulloch (27), Akiva Felt (5) | |||
| Website | http://www.franklintempleton.com | |||
| Fund Information | FTDZX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Fund Name | Franklin Biotechnology Discovery Fund Advisor Class | |||
| Category | Health | |||
| Sub-Category | Healthcare Sector Equity | |||
| Prospectus Objective | Specialty - Health | |||
| Inception Date | Sep 01, 2009 | |||
| Open/Closed To New Investors | Closed | |||
| Minimum Initial Investment | 100,000.00 | |||
| Minimum Subsequent Investment | -- | |||
| Front End Fee | -- | |||
| Back End Fee | -- | |||
| Dividends and Shares | FTDZX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield | 0.00% | |||
| Dividend | FTDZX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield (Forward) | 0.70% | |||
| Asset Allocation | FTDZX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash | 1.76% | |||
| Stock | 98.06% | |||
| U.S. Stock | 78.56% | |||
| Non-U.S. Stock | 19.50% | |||
| Bond | 0.00% | |||
| U.S. Bond | 0.00% | |||
| Non-U.S. Bond | 0.00% | |||
| Preferred | 0.18% | |||
| Convertible | 0.00% | |||
| Other Net | 0.00% | |||
| Price History | FTDZX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.79% | |||
| 30-Day Total Return | 2.56% | |||
| 60-Day Total Return | 0.13% | |||
| 90-Day Total Return | 5.66% | |||
| Year to Date Total Return | -2.54% | |||
| 1-Year Total Return | -5.79% | |||
| 2-Year Total Return | 18.16% | |||
| 3-Year Total Return | 29.43% | |||
| 5-Year Total Return | -1.23% | |||
| Price | FTDZX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Closing Price | -- | |||
| 1-Month Low Price | -- | |||
| 1-Month High Price | -- | |||
| 52-Week Low Price | -- | |||
| 52-Week Low Price (Date) | -- | |||
| 52-Week High Price | -- | |||
| 52-Week High Price (Date) | -- | |||
| NAV | FTDZX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Nav | $123.69 | |||
| 1-Month Low NAV | $120.82 | |||
| 1-Month High NAV | $126.18 | |||
| 52-Week Low NAV | $104.73 | |||
| 52-Week Low NAV (Date) | Apr 08, 2025 | |||
| 52-Week High NAV | $160.08 | |||
| 52-Week High Price (Date) | Sep 19, 2024 | |||
| Beta / Standard Deviation | FTDZX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.62 | |||
| Standard Deviation | 17.58 | |||
| Balance Sheet | FTDZX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Total Assets | 679.91M | |||
| Operating Ratios | FTDZX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Expense Ratio | 0.80% | |||
| Turnover Ratio | 21.87% | |||
| Performance | FTDZX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Last Bull Market Total Return | 6.90% | |||
| Last Bear Market Total Return | -11.75% | |||